Literature DB >> 8651876

Cerebrovascular complications of neurocysticercosis. Clinical and neuroimaging spectrum.

C Cantú1, F Barinagarrementeria.   

Abstract

OBJECTIVE: To describe the clinical and neuroimaging spectrum of cerebral Cysticercus arteritis to clarify the mechanisms of a stroke that is associated with neurocysticercosis.
DESIGN: Case series.
SETTING: Tertiary care center. PATIENTS: Sixty-five patients with strokes that were associated with neurocysticercosis. Based on the extension of cysticercosis, the study group was divided into patients with focal or diffuse cysticercal disease. Patients with focal affection were subdivided into those with small- and large-vessel angiitis. MEASURES: For each group. stroke syndromes, mode of onset, associated neurologic syndromes, neuroimaging features of cysticercosis and cerebral infarcts, angiographic and cerebrospinal fluid findings, and outcome were analyzed.
RESULTS: Thirty-five patients had focal cysticercosis (13 with small-and 22 with large-vessel angiitis), and 30 had diffuse disease with either small-or large-vessel involvement. A high frequency of subarachnoidal cysts was found, neighboring the ischemic area. Patients with focal cysticercosis has a vascular onset in 80% compared with 20% in those with diffuse cysticercosis (P<.001). Distinctive findings in diffuse cysticercosis were hydrocephalus (80%), multiple cerebral infarcts (64%), and mental disorders (43%) (P<.001). There was a close parallelism between the type of cysticercosis and the degree of cerebrospinal fluid inflammatory changes, reflecting in the outcome. Death or incapacitating sequelae were associated with diffuse cysticercosis, and total recovery was common in patients with focal disease and small-vessel angiitis, whereas intermediate morbimortality occurred with focal cysticercosis and large-vessel vasculitis.
CONCLUSION: Based on the distribution of cysticercal disease and the severity of concomitant chronic arachnoiditis, it is possible to identify a wide spectrum of cerebrovascular involvement caused by neurocysticercosis.

Entities:  

Mesh:

Year:  1996        PMID: 8651876     DOI: 10.1001/archneur.1996.00550030039021

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  28 in total

Review 1.  Taeniasis and cysticercosis.

Authors:  G C Cook
Journal:  J R Soc Med       Date:  1998-10       Impact factor: 5.344

Review 2.  Clinical symptoms, diagnosis, and treatment of neurocysticercosis.

Authors:  Hector H Garcia; Theodore E Nash; Oscar H Del Brutto
Journal:  Lancet Neurol       Date:  2014-11-10       Impact factor: 44.182

3.  NEUROLOGICAL INFECTIONS IN THE RETURNING INTERNATIONAL TRAVELER.

Authors:  May H Han; Melanie Walker; Joseph R Zunt
Journal:  Continuum (Minneap Minn)       Date:  2006-04

Review 4.  Hydrocephalus in neurocysticercosis.

Authors:  Hamilton Matushita; Fernando Campos Gomes Pinto; Daniel Dante Cardeal; Manoel Jacobsen Teixeira
Journal:  Childs Nerv Syst       Date:  2011-09-17       Impact factor: 1.475

5.  The importance of neurocysticercosis in stroke in rural areas of a developing Latin American country.

Authors:  Oscar H Del Brutto; Julio Lama
Journal:  Am J Trop Med Hyg       Date:  2013-07-08       Impact factor: 2.345

6.  Neurocysticercosis: an update.

Authors:  Christina M Coyle
Journal:  Curr Infect Dis Rep       Date:  2014-11       Impact factor: 3.725

Review 7.  Neurologic parasitic infections in immigrants and travelers.

Authors:  Kiran Thakur; Joseph Zunt
Journal:  Semin Neurol       Date:  2011-09-30       Impact factor: 3.420

Review 8.  Taenia solium Cysticercosis and Its Impact in Neurological Disease.

Authors:  Hector H Garcia; Armando E Gonzalez; Robert H Gilman
Journal:  Clin Microbiol Rev       Date:  2020-05-27       Impact factor: 26.132

9.  Transient hemifacial spasm associated with subarachnoid brainstem cysticercosis: a case report.

Authors:  R Revuelta Gutierrez; J L Soto-Hernández; R Suastegui-Roman; J Ramos-Peek
Journal:  Neurosurg Rev       Date:  1998       Impact factor: 3.042

Review 10.  Management of neurocysticercosis.

Authors:  Terrence Riley; A C White
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.